UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 814-01334 Palmer Square Capital BDC Inc. (Exact name of registrant as specified in its charter) | Maryland | 84-3665200 | | --- | --- | | (State or Other Jurisdiction of | (I.R.S. Em ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Form 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commissio ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-33092 Registrant's telephone number, including area code 781-221-2266 | Securities registered under Section 12(b) of the Act: | | | ...

– Top-Line Data from Phase 3 ENSURE Trials of Vidofludimus Calcium in Relapsing Multiple Sclerosis Expected by Year-End 2026 – Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update – Raised Proceeds of $200 Million in a Private Placement, with Potential for up to an Additional $200 Million – – Net Proceeds Expected to Fund Completion of Phase 3 ENSURE Trials in Relapsing Multiple Sclerosis, Initiation of Phase 3 Trial in Primary Progressive Multiple Sclerosis and Begin of Trans ...

2025 Highlights "We finished 2025 with strong momentum, executing on our growth strategy, strengthening the balance sheet, and enhancing our high‑value fiber businesses," said Ed McKay, President and Chief Executive Officer. "Our Asset-Backed Securitization refinancing will reduce annual cash interest expense by over $10 million and fully fund completion of our Glo Fiber build by the end of 2026. With Glo Fiber and Commercial Fiber serving as primary growth engines, we are well positioned for sustained long ...

Exhibit 99.1 INTERNATIONAL SEAWAYS REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS Cumulative Shareholder Returns to Exceed $1 Billion Since 2020 New York, NY – February 26, 2026 – International Seaways, Inc. (NYSE: INSW) (the "Company," "Seaways," or "INSW"), one of the largest tanker companies worldwide providing energy transportation services for crude oil and petroleum products, today reported results for the fourth quarter and full year 2025. HIGHLIGHTS & RECENT DEVELOPMENTS Annual and Quarterly Resu ...

Exhibit 99.1 Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results Richmond, VA, February 26, 2026 – Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today reported its financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update. "In 2025 we successfully completed Phase I of the Indivior Action Agenda – Generate Momentum," said Joe Ciaffoni, Chief Executive Officer. "We sharpened our focus on our highest growth opportunity, U.S. SUBLOCADE, estab ...

Exhibit 99.1 PAPA JOHNS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS Met or Exceeded Revised 2025 Financial Guidance Targets 2025 Global System-wide Restaurant Sales Increased 1% Fourth Quarter Global System-wide Restaurant Sales Decreased 1% Fourth Quarter Diluted EPS of $0.21 and Adjusted Diluted EPS of $0.34 Introduces Fiscal Year 2026 Outlook (a) (a) (b) Louisville, Kentucky (February 26, 2026) – Papa John's International, Inc. (Nasdaq: PZZA) ("Papa Johns ") (the "Company") today announ ...

Exhibit 99.1 Vistra Reports Fourth Quarter and Full-Year 2025 Results Earnings Release Highlights IRVING, Texas — Feb. 26, 2026 — Vistra Corp. (NYSE: VST) today reported its fourth quarter and full-year 2025 financial results and other highlights. "I am proud of the 2025 performance of our Vistra team – this was truly a transformational year for our company," said Jim Burke, president and CEO of Vistra. "With our One Team mindset, we achieved several strategic milestones, including a 20-year power purchase ...